Latest Aft Pharmaceuticals (ASX:AFP) News

Page 2

Page 2 of 2

How AFT Pharmaceuticals Plans to Triple Revenue by FY27 Amid Global Challenges

AFT Pharmaceuticals Hits NZD 208M Revenue, Eyes NZD 300M by FY27

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Victor Sage

22 May 2025

Why Did AFT Pharmaceuticals’ Profit Drop 23% Despite 6% Revenue Growth?

AFT Pharmaceuticals Grows Revenue 6% Despite 23% Profit Slide

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.

Ada Torres

22 May 2025